Last reviewed · How we verify

SD-101 Dermal Cream (6%) — Competitive Intelligence Brief

SD-101 Dermal Cream (6%) (SD-101 Dermal Cream (6%)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Dermatology.

phase 3 Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

SD-101 Dermal Cream (6%) (SD-101 Dermal Cream (6%)) — Scioderm, Inc.. SD-101 is a topical dermal cream formulation designed to treat skin conditions through a proprietary mechanism not publicly disclosed in detail.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
SD-101 Dermal Cream (6%) TARGET SD-101 Dermal Cream (6%) Scioderm, Inc. phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). SD-101 Dermal Cream (6%) — Competitive Intelligence Brief. https://druglandscape.com/ci/sd-101-dermal-cream-6. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: